Abstract
Antibiotic-associated diarrhea (AAD) is the most common complication of antibiotic therapy. Factors influencing the development of this pathology include the class and frequency of antibiotic administration, the patient’s age, the duration of hospitalization, coexisting diseases, and the concurrent use of drugs that reduce gastric acid secretion. The pathogenesis of AAD is largely attributed to alterations in the intestinal microbiota, the overgrowth of opportunistic microorganisms, and the direct toxicity of antibiotics to the intestinal lining. Less than 33% of AAD cases are caused by Clostridioides difficile, making the identification of other pathogenic etiological factors important. Treatment of AAD follows a stepwise approach and requires a systematic and comprehensive management plan. Prevention primarily involves the rational use of antibiotics and adherence to hygienic standards by healthcare providers.
References
McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol. 2008;3(5):563-578. DOI: 10.2217/17460913.3.5.563.
Скрипник АІ, Приходько НП. Антибіотикоасоційована діарея: роль пробіотиків у лікуванні та профілактиці. Укр. Мед. Часопис. 2021;2 (142) — III/IV. DOI: 10.32471/umj.1680-3051.142.203410.
McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol. 2008;3(5):563-578. doi:10.2217/17460913.3.5.563.
Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet. 2001;357(9251):189-193. doi: 10.1016/s0140-6736(00)03592-3.
Moshkowitz M, Ben Baruch E, Kline Z, Moshe G, Shimoni Z, Konikoff F. Clinical manifestations and outcome of Pseudomembranous colitis in an elderly population in Israel. Isr Med Assoc J. 2004;6:201-204.
Tedesco FJ, Barton RW, Alpers DH. Clindamycin-associated colitis. A prospective study. Ann Intern Med. 1974;81(4):429. doi: 10.7326/0003-4819-81-4-429.
Department of Health and Health Protection Agency. Clostridium difficile infection: How to deal with the problem. 2008. www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1204186173530
What to know about antibiotic-associated diarrhea Medically reviewed by Alana Biggers, M.D., MPH — Written by Zawn Villines on November 21, 2023. https://www.google.ru/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.medicalnewstoday.com/articles/antibiotics-diarrhea&ved=2ahUKEwjyktXqz8uLAxXrJxAIHUIUK3YQFnoECBUQAQ&usg=AOvVaw3EzYv5o_nG7OjPMWbGtDLd
Barker AK, Ngam C, Musuuza JS et al. Reducing Clostridium difficile in the Inpatient Settings: A Systematic Review of the Adherence to and Effectivness of C. difficile Prevention Bundles, Infect Control Hosp Epidemiol. 2017;38(6):639-650.
European Centre for Disease Prevention and Control. Clostridium difficile infections. In: ECDC. Annual epidemiological report for 2016. Stockholm; ECDC; 2018.
Hryniewicz W, Martirosian G, Ozorowski T. Zakażenia Clostridium difficile: Diagnostyka, terapia, profilaktyka. 2011. Narodowy Instytut Leków. Warszawa. 2011.